Curcumin-mediated modulation of immunogenic cancer cell death pathways

Dong Oh Moon1

  • 1Department of Biology Education, Daegu University, 201, Daegudae-ro, Gyeongsan-si, 38453, Gyeongsangbuk-do, Republic of Korea. domoon@daegu.ac.kr.

Molecular Biology Reports
|February 25, 2026
PubMed

Insights

Curcumin triggers immunogenic cell death (ICD) by inducing cellular stress and DAMP release, activating anti-tumor immunity. This highlights curcumin

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Immunogenic cell death (ICD) is a crucial process in cancer immunity, involving the release of danger-associated molecular patterns (DAMPs).
  • DAMPs like calreticulin, ATP, and HMGB1 activate immune cells, promoting anti-tumor responses.
  • Understanding the molecular mechanisms of ICD and DAMP release is vital for developing novel cancer therapies.

Purpose of the Study:

  • To review the molecular mechanisms by which curcumin modulates immunogenic cell death (ICD).
  • To explore how curcumin triggers ICD via endoplasmic reticulum stress, oxidative stress, calcium homeostasis, and ferroptosis.
  • To discuss tumor-specific variations in response to curcumin-induced ICD.

Main Methods:

  • Literature review focusing on molecular mechanisms of ICD and curcumin's role.
  • Analysis of signaling pathways involved in DAMP release.
  • Examination of curcumin's effects on cellular stress responses and cell death modalities.

Main Results:

  • Curcumin induces ICD through multiple pathways including ER stress, oxidative stress, calcium disruption, and ferroptosis.
  • The diverse effects of curcumin are influenced by tumor-specific stress-response capacities and metabolic vulnerabilities.
  • Curcumin's ability to modulate ICD pathways is linked to its potential in enhancing anti-tumor immunity.

Conclusions:

  • Curcumin effectively modulates immunogenic cell death through various molecular mechanisms.
  • Understanding these mechanisms provides a foundation for developing curcumin-based cancer immunotherapies.
  • Targeting tumor-specific vulnerabilities can optimize curcumin's efficacy in cancer treatment.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K